'Allhat' presentation slideshows

Allhat - PowerPoint PPT Presentation

JNC 7: Update on the Management of Hypertension

JNC 7: Update on the Management of Hypertension

JNC 7: Update on the Management of Hypertension. Julie Cooper, Pharm.D., BCPS Clinical Pharmacist Moses Cone Health System. Overview. Why JNC 7? New features and key messages of JNC 7 Patient evaluation Why prehypertension? The goal is to get to goal Approach to rational therapy

★ ★ ★ ★ ★

1.31k views • 91 slides
JNC 7: Update on the Management of Hypertension

JNC 7: Update on the Management of Hypertension

JNC 7: Update on the Management of Hypertension. Julie Cooper, Pharm.D., BCPS Clinical Pharmacist Moses Cone Health System. Overview. Why JNC 7? New features and key messages of JNC 7 Patient evaluation Why prehypertension? The goal is to get to goal Approach to rational therapy

★ ★ ★ ★ ★

1.1k views • 91 slides
ALLHAT: Optimal first-step therapy for hypertension

ALLHAT: Optimal first-step therapy for hypertension

ALLHAT: Optimal first-step therapy for hypertension. Eric J Topol MD Provost and Chief Academic Officer Chairman, Department of Cardiovascular Medicine The Cleveland Clinic Foundation Cleveland, OH

★ ★ ★ ★ ★

552 views • 38 slides
Heart Failure With Preserved And Impaired Systolic Left Ventricular Function In ALLHAT

Heart Failure With Preserved And Impaired Systolic Left Ventricular Function In ALLHAT

ALLHAT. Heart Failure With Preserved And Impaired Systolic Left Ventricular Function In ALLHAT. JB Kostis, B Davis, L Simpson, H Black, W Cushman, P Einhorn, M Farber, C Ford, D Levy, B Massie, S Nawaz For The ALLHAT Collaborative Research Group. ALLHAT. Antihypertensive Trial Design.

★ ★ ★ ★ ★

521 views • 31 slides
allhatresearch

allhatresearch

ALLHAT. New Research Opportunities. www.allhatresearch.org. ALLHAT. New Opportunities. ALLHAT ( www.allhat.org ) – Largest antihypertensive treatment trial S econd largest lipid-lowering trial ever conducted, L andmark cost-effectiveness study.

★ ★ ★ ★ ★

352 views • 22 slides
SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2)

SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2)

SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2). Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events or death from any cause HR = 0.89 (0.79-1.00), p=0.05 First events CVD: HR = 0.88 (0.77-1.01), p = 0.07

★ ★ ★ ★ ★

210 views • 6 slides
SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2)

SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2)

SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2). Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events or death from any cause HR = 0.89 (0.79-1.00), p=0.05 First events CVD: HR = 0.88 (0.77-1.01), p = 0.07

★ ★ ★ ★ ★

69 views • 6 slides

View Allhat PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Allhat PowerPoint presentations. You can view or download Allhat presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.